Is oral ampicillin (ampicillin) effective for treating Enterococcus faecalis urinary tract infections (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Ampicillin for E. faecalis UTI

Yes, oral ampicillin is highly effective for treating Enterococcus faecalis urinary tract infections and is the first-line treatment of choice, with recommended dosing of 500 mg orally every 8 hours for 7 days. 1, 2, 3

First-Line Treatment Recommendation

  • Ampicillin 500 mg orally every 8 hours for 7 days is the preferred first-line therapy for uncomplicated E. faecalis UTIs, achieving clinical eradication rates of 88.1% and microbiological eradication rates of 86%. 1, 2

  • Amoxicillin 500 mg orally every 8 hours for 7 days is an equivalent alternative with similar efficacy. 1, 3

  • The FDA specifically approves oral ampicillin for genitourinary tract infections caused by enterococci. 4

Why Ampicillin Works Even When Resistance is Reported

  • Ampicillin achieves extremely high urinary concentrations that can overcome high minimum inhibitory concentrations (MICs), making it effective even when in vitro susceptibility testing suggests resistance. 1, 5

  • This pharmacokinetic advantage means ampicillin can successfully treat lower urinary tract infections caused by ampicillin-resistant E. faecalis strains, as the urinary drug levels far exceed typical MIC breakpoints. 1, 6, 5

  • Recent data demonstrate that aminopenicillins are non-inferior to other antibiotics for enterococcal lower UTIs, with 83.1% clinical success rates at 14 days, even in cases with vancomycin-resistant enterococci (VRE). 6

Alternative Oral Options

  • Nitrofurantoin 100 mg orally every 6 hours for 7 days is an effective alternative with good in vitro activity against E. faecalis and resistance rates below 6%. 1, 2, 3

  • Fosfomycin 3 g as a single oral dose is FDA-approved specifically for E. faecalis UTIs and offers convenient single-dose therapy for uncomplicated infections. 1, 2, 3

Critical Pitfalls to Avoid

  • Do not use fluoroquinolones (ciprofloxacin, levofloxacin) due to high resistance rates of 46-47% in E. faecalis and unfavorable risk-benefit profiles for uncomplicated UTIs. 2, 3, 7

  • Always differentiate colonization from true infection before prescribing antibiotics, as asymptomatic bacteriuria with E. faecalis does not routinely require treatment. 1, 8

  • Obtain susceptibility testing before initiating therapy when possible, even for strains described as "pansensitive," as resistance patterns vary by institution. 1, 2, 3

Treatment Algorithm

  1. Confirm symptomatic UTI (dysuria, frequency, urgency, suprapubic pain) versus asymptomatic bacteriuria. 1, 8

  2. For uncomplicated E. faecalis UTI: Start ampicillin 500 mg PO every 8 hours for 7 days. 1, 2, 3

  3. If penicillin allergy: Use nitrofurantoin 100 mg PO every 6 hours for 7 days. 2

  4. For beta-lactamase producing strains: Switch to amoxicillin-clavulanate. 2

  5. For VRE UTI: Use fosfomycin 3 g single dose or nitrofurantoin 100 mg every 6 hours. 3, 8

Special Considerations

  • For complicated UTIs or pyelonephritis, longer treatment durations may be necessary beyond the standard 7 days. 1, 3

  • For hospitalized patients requiring IV therapy, use ampicillin 2 g IV every 4 hours. 3

  • The high urinary concentrations of ampicillin make it effective even against VRE strains when treating lower UTIs, despite in vitro resistance. 1, 6, 5

References

Guideline

Treatment for Enterococcus faecalis in Urine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Best Oral Antibiotic for Uncomplicated Pansensitive Enterococcus faecalis UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Urinary Tract Infections Caused by Enterococcus faecalis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Aminopenicillins for treatment of ampicillin-resistant enterococcal urinary tract infections.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.